Premier Biomedical, Inc. (OTCPK:BIEI) announced a private placement of a convertible promissory note for gross proceeds of $25,000 on October 3, 2019. The note carries a principal value of $150,000. The transaction included participation from new accredited investor, Green Coast Capital International SA. The issuance of the note is a part of the purchase agreement between the company and the investor. The note carries an interest of 12% per annum and is convertible into common stock of the company at a conversion price equal to the lowest trading price of the common stock during the 15 trading days prior to the conversion date. The note will mature on October 3, 2020. The note can be prepaid by the company at any time during the first 180 days following the issue date upon 10 days written notice to the investor for a cash amount equal to the sum of the then outstanding principal amount of the note and interest. The company issued the security pursuant to exemption provided under Regulation D.